Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Medical Oncology
•
Internal Medicine
•
Rheumatology
•
Hematology
•
General Rheumatology
•
Infectious Disease
•
Gastroenterology
•
Vaccines
•
immunizations
•
Allergy & Immunology
•
Nephrology
•
Immunosuppression
•
Cardiology
What is your approach to RSV vaccination in immunocompromised patients?
Related Questions
Would you use the pneumococcal conjugate-21 vaccine (Capvaxive) instead of the conjugate-20 (Prevnar-20) for routine vaccinations in immunosuppressed patients?
How do you counsel patients who experience diarrhea from mycophenolate mofetil (Cellcept)?
Do you routinely consider FDG PET/CT imaging for workup of fever of unknown origin?
Is it necessary to prescribe a steroid taper after two weeks of high-dose prednisone (60 mg daily)?
Are there any concerns with live vaccine innoculation and patients who are on denosumab?
Is there a role for nitazoxanide for treatment of norovirus gastroenteritis in immunocompromised patients?
Excluding CLL, in which patients would you screen for hypogammaglobulinemia?
Do you perform genetic testing when patients have persistent hypogammaglobulinemia after rituximab therapy?
What approaches can we take to initiate therapy and improve survival rates in patients with HLH?
How would you approach management of a patient with ESRD on the transplant list who is found to have high titer APS labs (ACL, B2GP1, LAC)?